Menu
Back to Journals » Journal of Hepatocellular Carcinoma
Journal of Hepatocellular Carcinoma
- View all (83)
- Volume 6, 2019 (9)
- Volume 5, 2018 (14)
- Volume 4, 2017 (16)
- Volume 3, 2016 (10)
- Volume 2, 2015 (17)
- Volume 1 , 2014 (17)
Journal Articles:
- 83 records -
Prospective Phase II trial of drug-eluting bead chemoembolization for liver transplant candidates with hepatocellular carcinoma and marginal hepatic reserve
Fidelman N, Johanson C, Kohi MP, Kolli KP, Kohlbrenner RM, Lehrman ED, Taylor AG, Kelley RK, Yao FY, Roberts JP, Kerlan RK
Journal of Hepatocellular Carcinoma 2019, 6:93-103
Published Date: 17 June 2019
Post-translational modifiers of liver kinase B1/serine/threonine kinase 11 in hepatocellular carcinoma
Delgado TC, Lopitz-Otsoa F, Martínez-Chantar ML
Journal of Hepatocellular Carcinoma 2019, 6:85-91
Published Date: 6 June 2019
Targeting myeloid-derived suppressor cells in the treatment of hepatocellular carcinoma: current state and future perspectives
Lu LC, Chang CJ, Hsu CH
Journal of Hepatocellular Carcinoma 2019, 6:71-84
Published Date: 7 May 2019
LI-RADS: a conceptual and historical review from its beginning to its recent integration into AASLD clinical practice guidance
Elsayes KM, Kielar AZ, Chernyak V, Morshid A, Furlan A, Masch WR, Marks RM, Kamaya A, Do RKG, Kono Y, Fowler KJ, Tang A, Bashir MR, Hecht EM, Jambhekar K, Lyshchik A, Rodgers SK, Heiken JP, Kohli M, Fetzer DT, Wilson SR, Kassam Z, Mendiratta-Lala M, Singal AG, Lim CS, Cruite I, Lee J, Ash R, Mitchell DG, McInnes MDF, Sirlin CB
Journal of Hepatocellular Carcinoma 2019, 6:49-69
Published Date: 5 February 2019
Road map for fibrolamellar carcinoma: progress and goals of a diversified approach
Kastenhuber ER, Craig J, Ramsey J, Sullivan KM, Sage J, de Oliveira S, Riehle KJ, Scott JD, Gordan JD, Bardeesy N, Abou-Alfa GK
Journal of Hepatocellular Carcinoma 2019, 6:41-48
Published Date: 31 January 2019
Lenvatinib for the treatment of unresectable hepatocellular carcinoma: evidence to date
Personeni N, Pressiani T, Rimassa L
Journal of Hepatocellular Carcinoma 2019, 6:31-39
Published Date: 31 January 2019
Weighing the benefits of hepatocellular carcinoma surveillance against potential harms
Geh D, Rana FA, Reeves HL
Journal of Hepatocellular Carcinoma 2019, 6:23-30
Published Date: 14 January 2019
Combined hepatocellular cholangiocarcinoma (cHCC-CC): an update of genetics, molecular biology, and therapeutic interventions
Stavraka C, Rush H, Ross P
Journal of Hepatocellular Carcinoma 2019, 6:11-21
Published Date: 28 December 2018
Selecting patients with hepatocellular carcinoma for liver transplantation: incorporating tumor biology criteria
Amado V, Rodríguez-Perálvarez M, Ferrín G, De la Mata M
Journal of Hepatocellular Carcinoma 2019, 6:1-10
Published Date: 21 December 2018
Sorafenib plus tegafur–uracil (UFT) versus sorafenib as first line systemic treatment for patients with advanced stage HCC: a Phase II trial (ESLC01 study)
Azim HA, Omar A, Atef H, Zawahry H, Shaker MK, Abdelmaksoud AHK, EzzElarab M, Abdel-Rahman O, Ismail M, Kassem L, Waked I
Journal of Hepatocellular Carcinoma 2018, 5:109-119
Published Date: 19 November 2018
Hepatocellular carcinoma: a review of diagnostic challenges for the pathologist
Quaglia A
Journal of Hepatocellular Carcinoma 2018, 5:99-108
Published Date: 8 November 2018
Potential of ramucirumab in treating hepatocellular carcinoma patients with elevated baseline alpha-fetoprotein
Gilabert M, Raoul JL
Journal of Hepatocellular Carcinoma 2018, 5:91-98
Published Date: 2 November 2018
Update on hepatocellular carcinoma from the 2018 Gastrointestinal Cancer Symposium (ASCO GI)
de Jesus VHF, Dettino ALA
Journal of Hepatocellular Carcinoma 2018, 5:87-90
Published Date: 3 October 2018
Hepatitis C virus-associated hepatocellular carcinoma as a second primary malignancy: exposing an overlooked presentation of liver cancer
Dandachi D, Hassan M, Kaseb A, Angelidakis G, Torres HA
Journal of Hepatocellular Carcinoma 2018, 5:81-86
Published Date: 2 August 2018
Hepatocellular cancer pain: impact and management challenges
Christian-Miller N, Frenette C
Journal of Hepatocellular Carcinoma 2018, 5:75-80
Published Date: 19 July 2018
Role of Wnt/β-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance
Khalaf AM, Fuentes D, Morshid AI, Burke MR, Kaseb AO, Hassan M, Hazle JD, Elsayes KM
Journal of Hepatocellular Carcinoma 2018, 5:61-73
Published Date: 27 June 2018
Decreased hepatocellular carcinoma tumor burden with the achievement of hepatitis C virus sustained virologic response: unlocking the potential of T-cell-mediated immunosurveillance
Griffith AS, Hayashi PH, Burke LMB, McRee AJ
Journal of Hepatocellular Carcinoma 2018, 5:55-59
Published Date: 31 May 2018
Editorial: charting the future of hepatocellular carcinoma publications
Kaseb AO
Journal of Hepatocellular Carcinoma 2018, 5:51-54
Published Date: 8 May 2018
Basic MRI for the liver oncologists and surgeons
Vu LN, Morelli JN, Szklaruk J
Journal of Hepatocellular Carcinoma 2018, 5:37-50
Published Date: 10 April 2018
Efficacy of loco-regional treatment for hepatocellular carcinoma prior to living donor liver transplantation: a report from a single center in Egypt
Shaker MK, Montasser IF, Sakr M, Elgharib M, Dabbous HM, Ebada H, El Dorry A, Bahaa M, El Meteini M
Journal of Hepatocellular Carcinoma 2018, 5:29-36
Published Date: 27 February 2018
Pretreatment neutrophil–lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinoma
Najjar M, Agrawal S, Emond JC, Halazun KJ
Journal of Hepatocellular Carcinoma 2018, 5:17-28
Published Date: 18 January 2018
Phase II trial of SOM230 (pasireotide LAR) in patients with unresectable hepatocellular carcinoma
Feun LG, Wangpaichitr M, Li YY, Kwon D, Richman SP, Hosein PJ, Savaraj N
Journal of Hepatocellular Carcinoma 2018, 5:9-15
Published Date: 12 January 2018
Liver resection versus radiofrequency ablation for hepatitis B virus-related small hepatocellular carcinoma
Liang B, Yao SY, Zhou JP, Li ZK, Liu TQ
Journal of Hepatocellular Carcinoma 2018, 5:1-7
Published Date: 12 January 2018
Characterization of alpha-fetoprotein effects on dendritic cell and its function as effector immune response activator
Suryatenggara J, Wibowo H, Atmodjo WL, Mathew G
Journal of Hepatocellular Carcinoma 2017, 4:139-151
Published Date: 28 November 2017
Optimal therapy for patients with hepatocellular carcinoma and resistance or intolerance to sorafenib: challenges and solutions
Ray EM, Sanoff HK
Journal of Hepatocellular Carcinoma 2017, 4:131-138
Published Date: 8 November 2017
Healthcare costs of transarterial chemoembolization in the treatment of hepatocellular carcinoma
Fateen W, Khan F, O’Neill RJ, James MW, Ryder SD, Aithal GP
Journal of Hepatocellular Carcinoma 2017, 4:123-130
Published Date: 16 October 2017
A Phase I trial using local regional treatment, nonlethal irradiation, intratumoral and systemic polyinosinic-polycytidylic acid polylysine carboxymethylcellulose to treat liver cancer: in search of the abscopal effect
de la Torre AN, Contractor S, Castaneda I, Cathcart CS, Razdan D, Klyde D, Kisza P, Gonzales SF, Salazar AM
Journal of Hepatocellular Carcinoma 2017, 4:111-121
Published Date: 7 August 2017
Transarterial chemoembolization for the treatment of hepatocellular carcinoma: a review
Sacco R, Tapete G, Simonetti N, Sellitri R, Natali V, Melissari S, Cabibbo G, Biscaglia L, Bresci G, Giacomelli L
Journal of Hepatocellular Carcinoma 2017, 4:105-110
Published Date: 27 July 2017
Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategies
Galun D, Srdic-Rajic T, Bogdanovic A, Loncar Z, Zuvela M
Journal of Hepatocellular Carcinoma 2017, 4:93-103
Published Date: 11 July 2017
Hepatocellular carcinoma: early-stage management challenges
Erstad DJ, Tanabe KK
Journal of Hepatocellular Carcinoma 2017, 4:81-92
Published Date: 23 June 2017
Screening for hepatocellular carcinoma: patient selection and perspectives
Fateen W, Ryder SD
Journal of Hepatocellular Carcinoma 2017, 4:71-79
Published Date: 17 May 2017
Open-label phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L
Tarakanovskaya MG, Chinburen J, Batchuluun P, Munkhzaya C, Purevsuren G, Dandii D, Hulan T, Oyungerel D, Kutsyna GA, Reid AA, Borisova V, Bain AI, Jirathitikal V, Bourinbaiar AS
Journal of Hepatocellular Carcinoma 2017, 4:59-69
Published Date: 12 April 2017
Irreversible electroporation of hepatocellular carcinoma: patient selection and perspectives
Zimmerman A, Grand D, Charpentier KP
Journal of Hepatocellular Carcinoma 2017, 4:49-58
Published Date: 13 March 2017
A single institution report of 19 hepatocellular carcinoma patients with bile duct tumor thrombus
Chotirosniramit A, Liwattanakun A, Lapisatepun W, Ko-iam W, Sandhu T, Junrungsee S
Journal of Hepatocellular Carcinoma 2017, 4:41-47
Published Date: 7 March 2017
Liver Imaging Reporting and Data System: an expert consensus statement
Elsayes KM, Kielar AZ, Agrons MM, Szklaruk J, Tang A, Bashir MR, Mitchell DG, Do RK, Fowler KJ, Chernyak V, Sirlin CB
Journal of Hepatocellular Carcinoma 2017, 4:29-39
Published Date: 17 February 2017
Needle track seeding after radiofrequency ablation for hepatocellular carcinoma: prevalence, impact, and management challenge
Francica G
Journal of Hepatocellular Carcinoma 2017, 4:23-27
Published Date: 20 January 2017
Pediatric hepatocellular carcinoma: challenges and solutions
Schmid I, von Schweinitz D
Journal of Hepatocellular Carcinoma 2017, 4:15-21
Published Date: 16 January 2017
Strengthening the case that elevated levels of programmed death ligand 1 predict poor prognosis in hepatocellular carcinoma patients
Zhong J, Luo C, Zhang C, Li L
Journal of Hepatocellular Carcinoma 2017, 4:11-13
Published Date: 30 December 2016
Surgical resection of localized hepatocellular carcinoma: patient selection and special consideration
Ma KW, Cheung TT
Journal of Hepatocellular Carcinoma 2017, 4:1-9
Published Date: 28 December 2016
Profile of tivantinib and its potential in the treatment of hepatocellular carcinoma: the evidence to date
Pievsky D, Pyrsopoulos N
Journal of Hepatocellular Carcinoma 2016, 3:69-76
Published Date: 15 November 2016
GPC-3 in hepatocellular carcinoma: current perspectives
Wu Y, Liu H, Ding H
Journal of Hepatocellular Carcinoma 2016, 3:63-67
Published Date: 8 November 2016
Minimally invasive image-guided therapies for hepatocellular carcinoma
Abdelsalam ME, Murthy R, Avritscher R, Mahvash A, Wallace MJ, Kaseb AO, Odisio BC
Journal of Hepatocellular Carcinoma 2016, 3:55-61
Published Date: 11 October 2016
Hepatocellular carcinoma: a review
Balogh J, Victor III D, Asham EH, Burroughs SG, Boktour M, Saharia A, Li X, Ghobrial RM, Monsour Jr HP
Journal of Hepatocellular Carcinoma 2016, 3:41-53
Published Date: 5 October 2016
Does alpha-fetoprotein contribute to the mortality and morbidity of human hepatocellular carcinoma? A commentary
Mizejewski GJ
Journal of Hepatocellular Carcinoma 2016, 3:37-40
Published Date: 21 September 2016
Role of regorafenib as second-line therapy and landscape of investigational treatment options in advanced hepatocellular carcinoma
Trojan J, Waidmann O
Journal of Hepatocellular Carcinoma 2016, 3:31-36
Published Date: 21 September 2016
Transarterial radioembolization for hepatocellular carcinoma: a review
Sacco R, Conte C, Tumino E, Parisi G, Marceglia S, Metrangolo S, Eggenhoffner R, Bresci G, Cabibbo G, Giacomelli L
Journal of Hepatocellular Carcinoma 2016, 3:25-29
Published Date: 25 July 2016
Clinical significance of vascular endothelial growth factor in hepatitis C related hepatocellular carcinoma in Egyptian patients
Atta MM, Atta HM, Gad MA, Rashed LA, Said EM, Hassanien SE, Kaseb AO
Journal of Hepatocellular Carcinoma 2016, 3:19-24
Published Date: 14 June 2016
Hepatocellular carcinoma in elderly patients: challenges and solutions
Brunot A, Le Sourd S, Pracht M, Edeline J
Journal of Hepatocellular Carcinoma 2016, 3:9-18
Published Date: 17 June 2016
Yttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellular carcinoma
Mahvash A, Murthy R, Odisio BC, Raghav KP, Girard L, Cheung S, Nguyen V, Ensor J, Gadani S, Elsayes KM, Abdel-Wahab R, Hassan M, Shalaby AS, Yao JC, Wallace MJ, Kaseb AO
Journal of Hepatocellular Carcinoma 2016, 3:1-7
Published Date: 5 February 2016
Fibrolamellar hepatocellular carcinoma: current clinical perspectives
Lafaro KJ, Pawlik TM
Journal of Hepatocellular Carcinoma 2015, 2:151-157
Published Date: 9 October 2015
Role of endoscopic ultrasound in diagnosis and management of hepatocellular carcinoma
Koduru P, Suzuki R, Lakhtakia S, Ramchandani M, Makmun D, Bhutani MS
Journal of Hepatocellular Carcinoma 2015, 2:143-149
Published Date: 6 October 2015
Type I insulin-like growth factor as a liver reserve assessment tool in hepatocellular carcinoma
Abdel-Wahab R, Shehata S, Hassan MM, Habra MA, Eskandari G, Tinkey PT, Mitchell J, Lee JS, Amin HM, Kaseb AO
Journal of Hepatocellular Carcinoma 2015, 2:131-142
Published Date: 18 September 2015
Transarterial chemoembolization for hepatocellular carcinoma: an evidence-based review of its place in therapy
Jang JH, Lee JW, Hong JT, Jin YJ
Journal of Hepatocellular Carcinoma 2015, 2:123-129
Published Date: 2 September 2015
Whither α-FP in the diagnosis of hepatocellular carcinoma?
Kew MC
Journal of Hepatocellular Carcinoma 2015, 2:119-121
Published Date: 24 August 2015
State-of-the-art cross-sectional liver imaging: beyond lesion detection and characterization
Luersen GF, Bhosale P, Szklaruk J
Journal of Hepatocellular Carcinoma 2015, 2:101-117
Published Date: 10 July 2015
The androgen receptor as an emerging target in hepatocellular carcinoma
Kanda T, Yokosuka O
Journal of Hepatocellular Carcinoma 2015, 2:91-99
Published Date: 26 June 2015
Ambovex® as a novel immunological modulator drug for the treatment of hepatocellular carcinoma (HCC) in the liver: a Phase II clinical trial
Salama H, Ahmad H, Elchagea I, Zekri AR, Medhat E, Bahnassy A, Lange M, Rabbat M, de la Torre AN, Punamiya P
Journal of Hepatocellular Carcinoma 2015, 2:79-89
Published Date: 22 June 2015
Emerging role of Hpo signaling and YAP in hepatocellular carcinoma
Valero V III, Pawlik TM, Anders RA
Journal of Hepatocellular Carcinoma 2015, 2:69-78
Published Date: 18 June 2015
Hapten-enhanced overall survival time in advanced hepatocellular carcinoma by ultro-minimum incision personalized intratumoral chemoimmunotherapy
Gao F, Jing P, Liu J, Lu YF, Zhang PC, Han W, Liu GL, Ru N, Cui GH, Sun CL, Che YB, Zhang HM, Hu QL, Wang HY, Wu YL, Guan CJ, Fu Q, Ma ZL, Yu BF
Journal of Hepatocellular Carcinoma 2015, 2:57-68
Published Date: 9 June 2015
Hepatocellular carcinoma ablation and possible immunity in the age of nanosecond pulsed electric fields
Beebe SJ
Journal of Hepatocellular Carcinoma 2015, 2:49-55
Published Date: 22 May 2015
Early α-fetoprotein response predicts survival in patients with advanced hepatocellular carcinoma treated with sorafenib
Lee SH, Kim BK, Kim SU, Park JY, Kim DY, Ahn SH, Han KH
Journal of Hepatocellular Carcinoma 2015, 2:39-47
Published Date: 28 April 2015
c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma
Granito A, Guidetti E, Gramantieri L
Journal of Hepatocellular Carcinoma 2015, 2:29-38
Published Date: 24 April 2015
A clinical perspective of the link between metabolic syndrome and hepatocellular carcinoma
Cauchy F, Belghiti J
Journal of Hepatocellular Carcinoma 2015, 2:19-27
Published Date: 23 February 2015
Emerging role of Toll-like receptor 4 in hepatocellular carcinoma
Yang J, Li M, Zheng QC
Journal of Hepatocellular Carcinoma 2015, 2:11-17
Published Date: 16 February 2015
Untreated hepatocellular carcinoma in Egypt: outcome and prognostic factors
Zeeneldin AA, Salem SE, Darwish AD, El-Gammal MM, Hussein MM, Saadeldin M
Journal of Hepatocellular Carcinoma 2015, 2:3-9
Published Date: 30 January 2015
Welcome to Journal of Hepatocellular Carcinoma
Kaseb AO
Journal of Hepatocellular Carcinoma 2015, 2:1-2
Published Date: 9 January 2015
Chemoembolization with drug-eluting microspheres (DEM-TACE) for hepatocellular carcinoma: single-center review of safety and efficacy
Bishay VL, Maglione K, Khanna R, Lee KM, Fischman AM, Lookstein RA, Kim E
Journal of Hepatocellular Carcinoma 2014, 1:187-193
Published Date: 27 November 2014
Emerging role of dual antiplatelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma
Aiolfi R, Sitia G
Journal of Hepatocellular Carcinoma 2014, 1:183-186
Published Date: 13 November 2014
Transarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developments
Cappelli A, Pettinato C, Golfieri R
Journal of Hepatocellular Carcinoma 2014, 1:163-182
Published Date: 3 November 2014
Potent efficacy signals from systemically administered oncolytic herpes simplex virus (HSV1716) in hepatocellular carcinoma xenograft models
Braidwood L, Learmonth K, Graham A, Conner J
Journal of Hepatocellular Carcinoma 2014, 1:149-161
Published Date: 16 October 2014
Radiological diagnosis of hepatocellular carcinoma
Bargellini I, Battaglia V, Bozzi E, Lauretti DL, Lorenzoni G, Bartolozzi C
Journal of Hepatocellular Carcinoma 2014, 1:137-148
Published Date: 9 September 2014
Emerging role of the peroxisome proliferator-activated receptor-gamma in hepatocellular carcinoma
Hsu HT, Chi CW
Journal of Hepatocellular Carcinoma 2014, 1:127-135
Published Date: 26 August 2014
Hepatocellular carcinoma: epidemiology and risk factors
Kew MC
Journal of Hepatocellular Carcinoma 2014, 1:115-125
Published Date: 13 August 2014
Telaprevir-containing regimen for treatment of hepatitis C virus infection in patients with hepatocellular carcinoma awaiting liver transplantation: a case series
Torres HA, Kaseb A, Mahale P, Miller E, Frenette C
Journal of Hepatocellular Carcinoma 2014, 1:109-114
Published Date: 16 July 2014
Clinical utility of imaging for evaluation of hepatocellular carcinoma
Murakami T, Tsurusaki M, Hyodo T, Imai Y
Journal of Hepatocellular Carcinoma 2014, 1:101-108
Published Date: 14 July 2014
Sorafenib in advanced hepatocellular carcinoma: current status and future perspectives
Hsu CH, Shen YC, Shao YY, Hsu C, Cheng AL
Journal of Hepatocellular Carcinoma 2014, 1:85-99
Published Date: 12 June 2014
New insights on the role of epigenetic alterations in hepatocellular carcinoma
Frau M, Feo CF, Feo F, Pascale RM
Journal of Hepatocellular Carcinoma 2014, 1:65-83
Published Date: 12 June 2014
Potential immunotherapeutic role of interleukin-2 and interleukin-12 combination in patients with hepatocellular carcinoma
Gabeen AA, Abdel-Hamid FF, El-Houseini ME, Fathy SA
Journal of Hepatocellular Carcinoma 2014, 1:55-63
Published Date: 9 June 2014
Fibroblast growth factor family as a potential target in the treatment of hepatocellular carcinoma
Coleman SJ, Grose RP, Kocher HM
Journal of Hepatocellular Carcinoma 2014, 1:43-54
Published Date: 29 May 2014
Critical analysis of the potential of targeting GPC3 in hepatocellular carcinoma
Ofuji K, Saito K, Yoshikawa T, Nakatsura T
Journal of Hepatocellular Carcinoma 2014, 1:35-42
Published Date: 21 May 2014
Micro-ribonucleic acids: potential noninvasive biomarkers for hepatocellular carcinoma
Li L, Diao W, Zen K
Journal of Hepatocellular Carcinoma 2014, 1:21-33
Published Date: 21 May 2014
Emerging role of insulin-like growth factor-binding protein 7 in hepatocellular carcinoma
Akiel M, Rajasekaran D, Gredler R, Siddiq A, Srivastava J, Robertson C, Jariwala NH, Fisher PB, Sarkar D
Journal of Hepatocellular Carcinoma 2014, 1:9-19
Published Date: 26 March 2014
A review on the diagnosis and treatment of hepatocellular carcinoma with a focus on the role of Wnts and the dickkopf family of Wnt inhibitors
Shi J, Keller JM, Zhang J, Keller ET
Journal of Hepatocellular Carcinoma 2014, 1:1-7
Published Date: 6 March 2014